ImageneBio Inc (IMA)

NASDAQ:IMA

ImageneBio Inc

—

Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis

1998

Founded

Country

—

CEO

—

Fulltime Employees

-1.75

PE Ratio

-0.08

Relative PE Ratio

0.00%

Dividend Yield

USD 5.69

Stock Price

+1.07%

1D Change

USD 15.79

52W High

USD 3.94

52W Low

52W Range

$91,960.19K

Market Cap

Revenue

$-52,484.00K

Net Income

Net Margin

$136,153.00K

Cash

$1,912.00K

Debt

$-42,280.81K

Enterprise Value

$-58,961.00K

Operating Profit

$-57,733.00K

Operating Cash Flow

CapEx

$-57,733.00K

Free Cash Flow

124.13 %

Net Income / EV

136.55 %

OCF / EV

136.55 %

FCF / EV

Actions

Website Investor Relations

AI Actions

Moat Analysis Key business risks Management Analysis Balance Sheet Analysis Normalize Earnings Growth Drivers Capital Allocation Latest News

—

Daily adjusted close

1998

Founded

Country

—

CEO

—

Fulltime Employees

0 USD

Revenue

-52.48M USD

Net Income

Net Margin

0.00%

Dividend Yield

-1.75

PE Ratio

-0.08

Relative PE Ratio

$15.79

52W High

$3.94

52W Low

52w Range

91.96M USD

Market Cap

136.15M USD

Cash

1.91M USD

Debt

-42.28M USD

Enterprise Value

-58.96M USD

Operating Profit

-57.73M USD

Operating Cash Flow

0 USD

CapEx

-57.73M USD

Free Cash Flow

124.13 %

Net Income / EV

136.55 %

OCF / EV

136.55 %

FCF / EV

Actions

Website Investor Relations

AI Actions

Explain Business Moat Analysis Key business risks Management Analysis Balance Sheet Analysis Normalize Earnings Growth Drivers Dividend Track Record Capital Allocation Latest News

$IMA

ImageneBio Inc

124.13 %

Net Income / EV

136.55 %

Operating Cash Flow / EV

136.55 %

Free Cash Flow / EV

Key stats based on share price of USD 5.69, as of 7, August 2026.

View more and calculate expected returns for free on www.aiir.finance

AIIR Finance

Key Stats

Market Cap$91,960.19K

- Cash$136,153.00K

+ Debt$1,912.00K

Enterprise Value$-42,280.81K

Revenue$0

Gross Profit_

Operating Profit$-58,961.00K

Net Income$-52,484.00K

Operating Cash Flow$-57,733.00K

CapEx$0

Free Cash Flow$-57,733.00K

Net Income / EV124.13 %

OCF / EV136.55 %

FCF / EV136.55 %